InsidersTradesSigma
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the complete record of transactions filed by Neervannan Seshadri. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 12 reports have been logged. Split: 0 buy · 7 sells. Total volume traded: €1.4m. Activity tracked since 17 March 2023. The latest transaction was filed on 4 September 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 de 12 declaraciones
Neervannan Seshadri is a declarant linked to Tarsus Pharmaceuticals, Inc., where the listed role is Chief Operating Officer. He has 11 filings in total, and in the sampled recent filings the activity consists entirely of sales, with sell volume of EUR 1032757 between 2023-03-17 and 2026-03-24.